Skip to main content

Name
Quentin Tsang

Tue, 09/17/2019 - 21:50

Dr. Carrier's address to Medical Grand Rounds was an example of "real-time" translational medicine happening right before our eyes. He brought forth novel research to a group of medical professionals and students and sought to provide insight and education to all regarding recent findings relating to VTE and cancer. This was extremely evident during his polling session of the audience during his lecture; who had changed their minds about DOACs (or anti-coagulants in general) in cancer patients? The room was split; a third that would consider using DOACs or anticoagulants, a third that began to start thinking about anticoagulants in cancer patients and a third that weren't convinced and were not going to change their minds. While it may seem disappointing that two-thirds of the audience did not put full faith in Dr. Carrier's findings, he was, in fact, able to convince a third of the room! That is the nature of translational medicine and knowledge translation: we will never be able to convince 100% of people, but if we're able to bring our findings to our colleagues and educate them (and hopefully inspire them) on new breakthroughs, we will be able to improve patient outcomes! To me, this was translational medicine happening in real-time.

I would like to thank Dr. Carrier for his time speaking with the Translational Medicine Graduate Cohort after rounds and inspiring thoughtful discussion.

Quentin Tsang, BScH - Kinesiology
MSc Translational Medicine '21 (Candidate)
Gastrointestinal Diseases Research Unit
Queen's University

Name
Quentin Tsang

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.